Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Ye Shang

Biographic Data

ID7275983
NAMEYe Shang
GIVEN NAMESYe
FAMILY NAMEShang
SIGNATURESHANG Y
AFFILIATIONSTianjin University of Traditional Chinese Medicine
ORCID0000-0002-4250-128X
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
AUTHOR COUNT4
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Investigation of the drug–drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit

    Open Access•Minglei Ge, Huizi Ouyang et al.•ARTICLE•Journal of Ethnopharmacology•2024

  • A comprehensive review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicity and quality control of Perillae Fructus

    Open Access•Suyi Liu, Xingyue Jin et al.•ARTICLE•Journal of Ethnopharmacology•2023

  • An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent medicine

    Open Access•Kunze Du, Kun-ze Du et al.•ARTICLE•Journal of Ethnopharmacology•2022

  • Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

    Open Access•Yingcheng Wang, Mingjun Rui et al.•ARTICLE•Frontiers in Public Health•2021

    Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US). Methods: The three health states partitioned survival (PS) model was used over the lifetime. Effectiveness and safety data were derived from the IMpower133 trial. The parametric survival model and mixture cure model were used for the atezolizu…

No prominent works on this page.

  • Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

    Open Access•Yingcheng Wang, Mingjun Rui et al.•ARTICLE•Frontiers in Public Health•2021

    Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US). Methods: The three health states partitioned survival (PS) model was used over the lifetime. Effectiveness and safety data were derived from the IMpower133 trial. The parametric survival model and mixture cure model were used for the atezolizu…

  • An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent medicine

    Open Access•Kunze Du, Kun-ze Du et al.•ARTICLE•Journal of Ethnopharmacology•2022

  • A comprehensive review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicity and quality control of Perillae Fructus

    Open Access•Suyi Liu, Xingyue Jin et al.•ARTICLE•Journal of Ethnopharmacology•2023

  • Investigation of the drug–drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit

    Open Access•Minglei Ge, Huizi Ouyang et al.•ARTICLE•Journal of Ethnopharmacology•2024

Medicine (4 works) · Pharmacology (3 works) · Biochemistry (2 works) · Chemistry (2 works) · Internal Medicine (2 works) · Plant-based Medicinal Research (2 works) · Traditional medicine (2 works) · Aconitine (1 works) · Alcohol Consumption and Health Effects (1 works) · Alkaloids: synthesis and pharmacology (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae